Syntara Completes Patient Recruitment for Phase-Two Bone Marrow Cancer Treatment Trial

MT NewswiresJul 31 23:08 ET

Syntara Raises About AU$5 Million for Clinical Trials, Studies; Shares Fall 25%

MT NewswiresJul 30 01:28 ET

Syntara Limited's Latest Cash Flow Report

TipRanksJul 29 23:47 ET

Syntara Ltd: Quarterly Activities Report

Jul 29 20:22 ET · Announcements

Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment

MT NewswiresApr 9 22:09 ET

Syntara to Begin Phase Two Study for SNT-5505 Combination Therapy Later in 2024 After Government Grant

MT NewswiresFeb 13 23:14 ET